This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Geneart Ag. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Innovations by Doris Leikam in Gene Expression Modulation
Introduction
Doris Leikam is a notable inventor based in Wuppertal, Germany. She has made significant contributions to the field of gene expression modulation. Her work focuses on nucleic acid modifications that enhance the targeted expression of genes.
Latest Patents
Doris Leikam holds a patent for a "Method for modulating gene expression by modifying the CpG content." This invention relates to nucleic acid modifications aimed at directed expression modulation through the targeted insertion or removal of CpG dinucleotides. The patent also encompasses modified nucleic acids and expression vectors, showcasing her innovative approach to genetic engineering.
Career Highlights
Leikam is associated with Geneart AG, a company known for its advancements in genetic research and development. Her role at Geneart AG has allowed her to explore and implement her innovative ideas in a collaborative environment.
Collaborations
Doris has worked alongside esteemed colleagues such as Ralf Wagner and Frank Notka. Their combined expertise contributes to the success of their projects and the advancement of genetic research.
Conclusion
Doris Leikam's contributions to gene expression modulation through her innovative patent highlight her role as a leading inventor in the field. Her work continues to influence advancements in genetic engineering and biotechnology.